Back
Grupo Supervielle SA Vs. Monopar Therapeutics Industry Stock Comparison
Buy
95
SUPV
Grupo Supervielle SA
Last Price:
15.80
Seasonality Move:
2.46%
Buy
75
MNPR
Monopar Therapeutics
Last Price:
30.47
Seasonality Move:
35.55%
Buy
95
Grupo Supervielle SA (SUPV)
is a Buy
Is Grupo Supervielle SA a Buy, Sell or Hold?
- The current Grupo Supervielle SA [SUPV] share price is $15.54. The Score for SUPV is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.
- SUPV is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPV Stock Price Chart
What is Grupo Supervielle SA's stock price today?
-
The Grupo Supervielle SA share price today is $15.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPV is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SUPV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 84.28 | Buy |
| Chaikin Money Flow: | -116242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.51 - 13.31) | Buy |
| Bollinger Bands (100): | (6.53 - 10.85) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 62338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.5 - 24.7) | Buy |
| Bollinger Bands (100): | (1.59 - 18.41) | Buy |
SUPV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.44 | Buy |
| 20-day SMA: | 12.28 | Buy |
| 50-day SMA: | 10.18 | Buy |
| 200-day SMA: | 7.45 | Buy |
| 8-day EMA: | 13.77 | Buy |
| 20-day EMA: | 12.49 | Buy |
| 50-day EMA: | 10.77 | Buy |
| 200-day EMA: | 7.76 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.74 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 16.57 | Buy |
| 200-day SMA: | 6.79 | Buy |
| 8-day EMA: | 25.62 | Buy |
| 20-day EMA: | 22.75 | Buy |
| 50-day EMA: | 17.67 | Buy |
| 200-day EMA: | 9.07 | Buy |
Grupo Supervielle SA Earnings Growth & SUPV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Grupo Supervielle SA Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||